Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, September 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy: 2 policy sources

twitter: 1 X user

Readers on

mendeley: 66 Mendeley

Summary Policy documents X

So far, Altmetric has seen 2 policy documents that reference this research output.

Chronic obstructive pulmonary disease: aclidinium/formoterol

Cited by National Institute for Health and Care Excellence on 28 Apr 2015

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Polyfarmacie bij kwetsbare ouderen : Inventarisatie van risico's en mogelijke interventiestrategieën

Cited by Rijksinstituut voor Volksgezondheid en Milieu on 23 Jul 2013

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment.

Dove Medical Press

Article Metrics